In 2016, the UMass Boston - DF/HCC U54 Partnership was renewed, receiving $17.8M from NCI. The grant is under the leadership of PIs Drs. Adán Colon-Carmona, Jill Macoska (UMass Boston) and K. "Vish" Viswanath (DF/HCC).
The UMass Boston - DF/HCC Partnership began in 2002 when Dr. Paul Fonteyn, former Provost of UMass Boston started a dialogue with DF/HCC senior leaders Dr. Karen M. Emmons and Ms. Karen Burns White. Prior to this time, no relationship of any kind existed between the two institutions. Upon exploration, the potential UMass Boston - DF/HCC partnership seemed as though it would create a “perfect storm” of sorts.
In 2005, the UMass Boston - DF/HCC $4.2M U56 grant was funded by the National Institute of Health (NIH). Under the leadership of Dr. Karen Emmons and Dr. Adan Colon Carmona (UMass Boston), the U56 Mechanism produced great results and funded many collaborative research projects.
The early years of the Partnership during the U56 funding period (2005-2010) established the foundational support and scientific leadership needed to build a promising joint research collaboration, and in 2010, the UMass Boston-DF/HCC Partnership received the NCI U54 grant totaling $13.7M. The U54 grant was led by PIs Drs. Adan Colon-Carmona (UMass Boston) and K. "Vish" Viswanath (DF/HCC) who are closely supported by the CPCT Director and Alton J. Brann Endowed Chair, Dr. Jill A. Macoska (UMass Boston). The U54 mechanism has significantly advanced research capacity, education, and outreach at UMass Boson and DF/HCC.
In 2016, the UMass Boston - DF/HCC U54 mechanism was renewed and, under the continued leadership of Drs. Colon-Carmona, Macoska, and Viswanath are committed to further developing a shared rigorous and collaborative transdisciplinary cancer and disparities-related research program that spans the continuum of “Cells to Society.” The leadership is fully committed to elevating the U54 Partnership to make an impact on society and educating those affected by cancer.